Riskpilot← Back to searchSign inGet full accessARBE Consult AB
ABActiveOrg 5592089030Hugo Alfvéns Väg 16 Lgh: 56Medical specialists activities · NACE 8622Est. 20190 employees
Revenue 2024
SEK 2M
-2% vs 2023
EBITDA margin
27.1%
+60% vs 2023
Equity ratio
82.6%
Financial strength
Net profit 2024
SEK 417K
+1489% vs 2023
| Revenue | SEK 2M | -2% |
| EBITDA | SEK 539K | +60% |
| Net profit | SEK 417K | +1489% |
| Total assets | SEK 1,6M | -19% |
| Equity | SEK 1,3M | +2% |
| Employees | 0 | — |
Legal name
ARBE Consult AB
Org number
5592089030
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 juni 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva vårdtjänster inom psykiatri, läkarmottagning, medicinsk akademisk utbildning, psykiatriska utredningar samt konsult via applikationer inom psykiatri via Web och därmed förenlig verksamhet.
Address
Hugo Alfvéns Väg 16 Lgh: 56
Email
areti11@yahoo.gr
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 108 | 2 138 | 2 048 | 2 041 | 1 990 |
| Staff expenses | — | — | −1 148 | −1 344 | −1 278 |
| EBITDA | 963 | 972 | 410 | 338 | 539 |
| Depreciation & amort. | −0 | −0 | — | −6 | −18 |
| EBIT | 963 | 972 | 410 | 332 | 521 |
| Net financials | — | — | 1 | −377 | 26 |
| Profit before tax | 763 | 919 | 517 | 154 | 547 |
| Tax | −157 | −189 | −195 | −128 | −130 |
| Net profit | 606 | 730 | 321 | 26 | 417 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 425 | 2 397 | 2 307 | 1 984 | 1 611 |
| Equity | 686 | 1 276 | 1 277 | 1 304 | 1 330 |
| Long-term debt | 45 | 80 | 0 | — | — |
| Short-term debt | 439 | 735 | 830 | 680 | 280 |
| Total debt | 484 | 815 | 830 | 680 | 280 |
EBITDA margin
27.1%
This company
15.8%
Market median
+72% vs market
20202024
Equity ratio
82.6%
This company
38.2%
Market median
+116% vs market
20202024
Return on equity
31.3%
This company
18.4%
Market median
+70% vs market
20202024
Net profit margin
20.9%
This company
8.1%
Market median
+158% vs market
20202024
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
20202024
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ARBE Consult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Areti Bellou | Chief Executive Officer | 0 companies |
| Bruno Jean-Bernard Roussel | Deputy Board Member | 0 companies |